Brightsurf Science News & Current Events

May 25, 2002
First study of Viagra(R) in black men demonstrates treatment as effective, well tolerated
In the first study to evaluate the efficacy and safety of Viagra (R)(sildenafil citrate) in black men with erectile dysfunction (ED), approximately eight out of 10 patients reported improvement in their erectile function and ability to have sexual intercourse after taking Viagra for six weeks, according to data scheduled for presentation at the annual meeting of the American Urological Association.

Muscle derived cell transplants offer alternative incontinence therapy says Pitt study
Researchers from the University of Pittsburgh School of Medicine have found that, in animal models, autologous skeletal muscle derived cell (MDC) transplants offer a safer, more effective and longer lasting treatment for urinary incontinence than existing methods.

University of Pittsburgh researchers use botox to treat overactive bladder
Botulinum toxin A (BTX) injections, commonly known as botox, show promise as a treatment for a variety of lower urinary tract dysfunctions, according to a study presented by University of Pittsburgh researchers at the American Urological Association Centennial Celebration Annual Meeting.

First ethnicity-specific erectile dysfunction study shows prevalence among Hispanic American men
In the first study to estimate race and ethnic-specific prevalence rates of erectile dysfunction (ED) in the United States among men aged 40 and older, approximately 20 percent of Hispanic American men were found to have moderate to severe ED, according to data presented at the annual meeting of the American Urological Association is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to